Additionally, we investigated in depth the expression of CKS2 in various histological subtypes of invasive lung adenocarcinoma and identified the roles of CKS2 in affecting the drug sensitivity of LUAD tumor cells to carboplatin and paclitaxel. The gene discussed is CKS2; the disease is neoplasm.